Deisseroth AB - Search Results

1

Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.

DeGregorio MW, King OY, Holleran WM, Wilbur BJ, Cadman EC, Deisseroth AB, Wilbur JR. DeGregorio MW, et al. Among authors: deisseroth ab. Cancer Treat Rep. 1985 Dec;69(12):1441-2. Cancer Treat Rep. 1985. PMID: 4075318

2

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer.

Gandara DR, DeGregorio MW, Wold H, Wilbur BJ, Kohler M, Lawrence HJ, Deisseroth AB, George CB. Gandara DR, et al. Among authors: deisseroth ab. J Clin Oncol. 1986 Dec;4(12):1787-93. doi: 10.1200/JCO.1986.4.12.1787. J Clin Oncol. 1986. PMID: 3023557

3

Clinical pharmacology of high-dose cisplatin by Corden et al.

DeGregorio MW, Wilbur JR, Crowley TJ, Cadman EC, Deisseroth AB. DeGregorio MW, et al. Among authors: deisseroth ab. Cancer Chemother Pharmacol. 1985;15(2):183-4. doi: 10.1007/BF00257536. Cancer Chemother Pharmacol. 1985. PMID: 4040442 No abstract available.

4

Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen.

Gandara DR, Wold H, Perez EA, Deisseroth AB, Doroshow J, Meyers F, McWhirter K, Hannigan J, De Gregorio MW. Gandara DR, et al. Among authors: deisseroth ab. J Natl Cancer Inst. 1989 May 10;81(10):790-4. doi: 10.1093/jnci/81.10.790. J Natl Cancer Inst. 1989. PMID: 2541260

5

Successful continuation of cisplatin therapy after partial recovery from acute renal failure.

Wong DC, Deisseroth AB. Wong DC, et al. Among authors: deisseroth ab. Cancer Treat Rep. 1985 Jun;69(6):731-3. Cancer Treat Rep. 1985. PMID: 4040425 No abstract available.

6

Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen.

Ozols RF, Deisseroth AB, Javadpour N, Barlock A, Messerschmidt GL, Young RC. Ozols RF, et al. Among authors: deisseroth ab. Cancer. 1983 May 15;51(10):1803-7. doi: 10.1002/1097-0142(19830515)51:10<1803::aid-cncr2820511008>3.0.co;2-f. Cancer. 1983. PMID: 6187426

7

Phase I trial of Staphylococcus aureus Cowan I immunoperfusion.

Messerschmidt G, Bowles C, Dean D, Parker M, Lester R, Dowling R, Holohan T, Osborne L, Schaff BF, McCormack K, Corbitt R, Phillips T, Glatstein E, Deisseroth A. Messerschmidt G, et al. Cancer Treat Rep. 1982 Dec;66(12):2027-31. Cancer Treat Rep. 1982. PMID: 7139644

8

The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms.

Deisseroth A, Abrams RA. Deisseroth A, et al. Cancer Treat Rep. 1979 Mar;63(3):461-71. Cancer Treat Rep. 1979. PMID: 371800 No abstract available.

9

Rapidly alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: results of a phase I/II study.

Gandara DR, Valone FH, Perez EA, Deisseroth AB, Roach M 3rd, Ahn DK, Phillips T. Gandara DR, et al. Among authors: deisseroth ab. Int J Radiat Oncol Biol Phys. 1991 May;20(5):1047-52. doi: 10.1016/0360-3016(91)90203-g. Int J Radiat Oncol Biol Phys. 1991. PMID: 1850719 Clinical Trial.

10

Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.

Valone FH, Gandara DR, Deisseroth AB, Perez EA, Rayner A, Aronson FR, Luce J, Paradise C. Valone FH, et al. Among authors: deisseroth ab. J Immunother (1991). 1991 Jun;10(3):207-13. doi: 10.1097/00002371-199106000-00007. J Immunother (1991). 1991. PMID: 1651106 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters